NO20003284D0 - Farmasøytisk preparat for oral administrering - Google Patents

Farmasøytisk preparat for oral administrering

Info

Publication number
NO20003284D0
NO20003284D0 NO20003284A NO20003284A NO20003284D0 NO 20003284 D0 NO20003284 D0 NO 20003284D0 NO 20003284 A NO20003284 A NO 20003284A NO 20003284 A NO20003284 A NO 20003284A NO 20003284 D0 NO20003284 D0 NO 20003284D0
Authority
NO
Norway
Prior art keywords
oral administration
pharmaceutical preparation
pharmaceutical
preparation
oral
Prior art date
Application number
NO20003284A
Other languages
English (en)
Other versions
NO20003284L (no
Inventor
Claude Aleman
Philippe Bastard
Marielle Bonnel
Thierry Breul
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20003284D0 publication Critical patent/NO20003284D0/no
Publication of NO20003284L publication Critical patent/NO20003284L/no

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
NO20003284A 1997-12-24 2000-06-22 Farmasøytisk preparat for oral administrering NO20003284L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9716529A FR2772614B1 (fr) 1997-12-24 1997-12-24 Solution aqueuse a base de chlorhydrate de 1- [ 2-(2-naphtyl)ethyl]-4- (3-trifluoromethylphenyl) -1,2,3,6-tetrahydropyridine et composition pharmaceutique buvable en contenant
PCT/FR1998/002712 WO1999033466A1 (fr) 1997-12-24 1998-12-14 Composition pharmaceutique buvable

Publications (2)

Publication Number Publication Date
NO20003284D0 true NO20003284D0 (no) 2000-06-22
NO20003284L NO20003284L (no) 2000-08-24

Family

ID=9515152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003284A NO20003284L (no) 1997-12-24 2000-06-22 Farmasøytisk preparat for oral administrering

Country Status (25)

Country Link
US (1) US6191137B1 (no)
EP (1) EP1041984B1 (no)
JP (1) JP2002510599A (no)
AR (1) AR017722A1 (no)
AT (1) ATE252384T1 (no)
AU (1) AU1880599A (no)
BR (1) BR9814414A (no)
CA (1) CA2315696C (no)
CO (1) CO4970813A1 (no)
DE (1) DE69819203T2 (no)
DK (1) DK1041984T3 (no)
DZ (1) DZ2676A1 (no)
ES (1) ES2209238T3 (no)
FR (1) FR2772614B1 (no)
GT (1) GT199800204A (no)
HU (1) HUP0101012A3 (no)
MY (1) MY117156A (no)
NO (1) NO20003284L (no)
PT (1) PT1041984E (no)
SA (2) SA99191002B1 (no)
SI (1) SI1041984T1 (no)
TW (1) TW536409B (no)
UY (1) UY25320A1 (no)
WO (1) WO1999033466A1 (no)
ZA (1) ZA9811824B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070053883A1 (en) * 2003-03-25 2007-03-08 The Johns Hopkins University Neuronal cell lineages and methods of production thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702656B1 (fr) * 1993-03-18 1995-06-16 Sanofi Elf Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments cardioprotecteurs.

Also Published As

Publication number Publication date
CO4970813A1 (es) 2000-11-07
PT1041984E (pt) 2004-02-27
HUP0101012A3 (en) 2002-12-28
GT199800204A (es) 2000-06-14
AU1880599A (en) 1999-07-19
EP1041984B1 (fr) 2003-10-22
FR2772614A1 (fr) 1999-06-25
DE69819203T2 (de) 2004-07-15
TW536409B (en) 2003-06-11
DZ2676A1 (fr) 2004-09-19
NO20003284L (no) 2000-08-24
HUP0101012A2 (hu) 2001-08-28
ZA9811824B (en) 1999-06-29
WO1999033466A1 (fr) 1999-07-08
SA99191003B1 (ar) 2006-10-02
FR2772614B1 (fr) 2000-03-10
CA2315696A1 (en) 1999-07-08
EP1041984A1 (fr) 2000-10-11
DK1041984T3 (da) 2004-02-16
UY25320A1 (es) 2000-10-31
SA99191002B1 (ar) 2006-03-07
AR017722A1 (es) 2001-09-12
MY117156A (en) 2004-05-31
US6191137B1 (en) 2001-02-20
BR9814414A (pt) 2000-10-10
JP2002510599A (ja) 2002-04-09
CA2315696C (en) 2008-01-29
ES2209238T3 (es) 2004-06-16
SI1041984T1 (en) 2004-04-30
DE69819203D1 (de) 2003-11-27
ATE252384T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
NO973612L (no) Nytt farmasöytisk preparat
DK0754061T3 (da) Ny oral farmaceutisk doseringsform
DK0936913T4 (da) Oralt farmaceutisk præparat indeholdende ibandronat
NO996372L (no) Fast farmasøytisk preparat inneholdende benzofuanderivater
NO20014035D0 (no) System for oral administrasjon av medikament
NO20005399D0 (no) Farmasøytisk preparat
ATE432707T1 (de) Pharmazeutische zubereitung
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
NO20015149L (no) Nytt farmasöytisk preparat
PT868911E (pt) Formulacoes de rapamicina para administracao oral
NO20015148L (no) Nytt farmasöytisk preparat
NO995039L (no) Gastrisk bibeholdt farmasoeytisk preparat
NO973610D0 (no) Nytt farmasöytisk preparat
NO992999D0 (no) Farmas°ytisk blanding for oral administrering
NO996044L (no) Rapamycinformuleringer for oral administrasjon
NO20015104D0 (no) Nytt farmasöytisk preparat
NO973611D0 (no) Nytt farmasöytisk preparat
NO950950D0 (no) Farmasöytisk preparat
NO20015105D0 (no) Nytt farmasöytisk preparat
NO20021036D0 (no) Farmasöytisk preparat
NO20003284L (no) Farmasøytisk preparat for oral administrering
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
SI0927031T1 (en) Pharmaceutical preparation containing nimesulide for oral administration

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application